Correction: NAMPT/SIRT2-mediated inhibition of the p53-p21 signaling pathway is indispensable for maintenance and hematopoietic differentiation of human iPS cells

• Yun Xu,
• Masoud Nasri,
• Benjamin Dannenmann,
• Perihan Mir,
• Azadeh Zahabi,
• Karl Welte,
• Tatsuya Morishima,
• Julia Skokowa

Affiliations

Yun Xu

Department of Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tübingen

Masoud Nasri

Department of Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tübingen

Benjamin Dannenmann

Department of Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tübingen

Perihan Mir

Department of Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tübingen

Azadeh Zahabi

Department of Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tübingen

Karl Welte

University Children’s Hospital Tübingen

Tatsuya Morishima

Department of Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tübingen

Julia Skokowa

Department of Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tübingen